CCND1 and hepatocellular carcinoma: These effects were associated with the upregulation of Rb, p53, p21, and p27 and the downregulation of cyclin D1, cyclin E, CDK4, and phospho-Rb, which offer mechanistic insight for their further exploitation in HCC treatment [102].